Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo

Journal of Photochemistry and Photobiology B: Biology

Volumn 40, Issue 1, 1997, Pages 76-83

  Abels, C ^a,c   Fritsch, C ^b   Bolsen, K ^b   Szeimies, R M ^c   Ruzicka, T ^b   Goerz, G ^b   Goetz, A E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Haem biosynthesis; Laser; PDT; Tumour

Indexed keywords

AMINOLEVULINIC ACID; COPROPORPHYRIN; FERROCHELATASE; PHOTOFRIN; PORPHYRIN; PROTOPORPHYRIN; UROPORPHYRIN;

AMELANOTIC MELANOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE LEVEL; FLUORESCENCE; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MALE; MICROVASCULATURE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PORPHYRIN METABOLISM; PRIORITY JOURNAL; SKIN; TISSUE LEVEL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

AMINOLEVULINIC ACID; ANIMALS; CRICETINAE; ERYTHROCYTES; INJECTIONS, INTRAVENOUS; MALE; MELANOMA, AMELANOTIC; MESOCRICETUS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SKIN; SKIN NEOPLASMS; TIME FACTORS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030775055     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(97)00027-4     Document Type: Article

References (49)

1. H. Pass, Photodynamic therapy in oncology: mechanisms and clinical use, J. Natl. Cancer Inst. 85 (1993) 443-445.
2. R. van Hillegersberg, W.J. Kort, T.T. Onno, J.H.P. Wilson, Current status of photodynamic therapy in oncology, Drugs 48 (1994) 510-527.
3. T.J. Dougherty, M.T. Cooper, T.S. Mang, Cutaneous phototoxic occurrences in patients receiving Photofrin, Lasers Surg. Med. 10 (1990) 485-488.
4. C.J. Tralau, H. Barr, R. Sanderman, T. Barton, M.R. Lewin, S.G. Bown, Aluminum sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas, Photochem. Photobiol. 46 (1987) 777-781.
5. I. Rosenthal, Phthalocyanines as photodynamic sensitizers, Photochem. Photobiol. 53 (1991) 859-870.
6. J.D. Spikes, Chlorins as photosensitizers in biology and medicine, J. Photochem. Photobiol. B: Biol. 6 (1990) 259-274.
7. H.-B. Ris, H.J. Altermatt, R. Inderbitzi, R. Hess, B. Nachbur, J.C.M. Stewart, Q. Wang, C.K. Lim, R. Bonnett, M.C. Berenbaum, U. Althaus, Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results, Br. J. Cancer 64 (1991) 1116-1120.
8. M. Guardiano, R. Biolo, G. Jori, K. Schaffner, Tetra-n-propylporphycene as a tumour localizer: pharmacokinetic and phototherapeutic studies in mice, Cancer Lett. 44 (1989) 1-6.
9. C. Richert, J.M. Wessels, M. Müller, M. Kisters, T. Benninghaus, A.E. Goetz, Photodynamic antitumor agents: beta-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity, J. Med. Chem. 37 (1994) 2797-2807.
10. J.C. Kennedy, R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol. 14 (1992) 275-292.
11. E.W. Grant, C. Hopper, A.J. MacRobert, P.M. Speight, S.G. Bown, Photodynamic therapy of oral cancer: photosensitization with systemic aminolaevulinic acid, Lancet 342 (1993) 147-148.
12. R.-M. Szeimies, T. Sassy, M. Landthaler, Penetration potency of topical applied δ-aminolevulinic acid for photodynamic therapy of basal cell carcinoma, Photochem. Photobiol. 59 (1994) 73-76.
13. W.J. Williams (Ed.), Hematology, 4th ed., McGraw-Hill, New York, 1990.
14. H.A. Dailey, A. Smith, Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase, Biochem. J. 223 (1984) 441-445.
15. R. van Hillegersberg, J.W.O. van den Berg, W.J. Kort, T.T. Onno, J.H.P. Wilson, Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats, Gastroenterology 103 (1992) 647-651.
16. C. Abels, P. Heil, M. Dellian, G.E.H. Kuhnle, R. Baumgartner, A.E. Goetz, In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster, Br. J. Cancer 70 (1994) 826-833.
17. K. Rittenhouse-Diakun, H. van Leengoed, J. Morgan, E. Hryhorenko, G. Paskiewicz, J.E. Whitaker, A.R. Oseroff, The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor δ-aminolevulinic acid (ALA), Photochem. Photobiol. 61 (1995) 523-528.
18. M. Kriegmair, R. Baumgartner, R. Knüchel, A. Ehsan, P. Steinbach, W. Lumper, F. Hofstädter, A. Hofstetter, Photodynamische Diagnose urothelialer Neoplasien nach intravesikaler Instillation von 5-Aminolävulinsäure, Urologe 33 (1994) 270-275.
19. P. Wolf, E. Rieger, H. Kerl, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid, J. Am. Acad. Dermatol. 28 (1993) 17-21.
20. J. Regula, A.J. MacRobert, A. Gorchein, G.A. Buonarcorsi, S.M. Thorpe, G.M. Spencer, A.R.W. Hatfield, S.G. Bown, Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5-aminolaevulinic acid induced protoporphyrin IX - a pilot study, Gut 36 (1995) 67-75.
21. S. Karrer, R.-M. Szeimies, U. Hohenleutner, A. Heine, M. Landthaler, Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid, Dermatology 190 (1995) 218-222.
22. W.H. Boehncke, W. Sterry, R. Kaufmann, Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343 (1994) 801.
23. R.-M. Szeimies, S. Karrer, A. Sauerwald, M. Landthaler, Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study, Dermatology 192 (1996) 246-251.
24. P. Mlkvy, H. Messmann, J. Regula, M. Conio, M. Pauer, C.E. Millson, A.J. MacRobert, S.G. Bown, Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study, Neoplasma 42 (1995) 109-113.
25. R.-M. Szeimies, C. Abels, C. Fritsch, S. Karrer, P. Steinbach, W. Bäumler, G. Goerz, A.E. Goetz, M. Landthaler, Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo, J. Invest. Dermatol. Vol. 107 (1995) 672-677.
26. J.G. Fortner, A.G. Mahy, G.R. Schrodt, Transplantable tumors of the Syrian (Golden) hamster. Part I: Tumors of the alimentary tract, endocrine glands and melanomas, Cancer Res. 21 (1961) 161-198.
27. M. Dellian, S. Walenta, F. Gamarra, G.E.H. Kuhnle, W. Müller-Klieser, A.E. Goetz, High-energy shock waves enhance hyperthermic response of tumors: effects on blood flow, energy metabolism and tumor growth, J. Natl. Cancer Inst. 86 (1994) 287-293.
28. S. Piomelli, P. Young, G. Gay, A micromethod for free erythrocyte porphyrins: the FEP test, J. Lab. Clin. Med. 81 (1973) 932-940.
29. W. Vizethum, T. Ruzicka, G. Goerz, Inducibility of drug-metabolizing enzymes in the rat skin, Chem. Biol. Interact. 31 (1980) 215-219.
30. A. Seubert, S. Seubert, High-performance liquid chromatographic analysis of porphyrins and their isomers with radial compression columns, Anal. Biochem. 124 (1982) 303-307.
31. M. Leunig, A. Leunig, P. Lankes, A.E. Goetz, Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumor eradication, Int. J. Hyperthermia 10 (1994) 297-306.
32. M.M. Tomayko, C.P. Reynolds, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol. 24 (1989) 148-154.
33. N. Weiss, M. Delius, S. Gambihler, P. Dirschedl, A.E. Goetz, W. Brendel, Influence of the shock wave application mode on the growth of A-Mel-3 and SSK2 tumors in vivo, Ultrasound Med. Biol. 16 (1990) 595-605.
34. R.B. Livingston, S.K. Carter, Experimental design and clinical trials: clinical perspectives, in: S.K. Carter, S.K. Glatstein, R.B. Livingston (Eds.), Principles of Cancer Treatment, McGraw-Hill, New York, 1982, pp. 34-45.
35. A. Brun, S. Sandberg, Mechanisms of photosensitivity in porphyric patients with special emphasis on erythropoietic protoporphyria, J. Photochem. Photobiol. B: Biol. 10 (1991) 285-302.
36. P. Vaupel, W. Müller-Klieser, Interstitieller Raum und Mikromilieu in malignen Tumoren, in: P. Vaupel, F. Hammersen (Eds.), Mikrozirkulation in malignen Tumoren, Mikrozirkulation in Forschung und Klinik, Vol. 2, Karger, Basel, 1983, pp. 52-68.
37. D.L. Stout, F.F. Becker, Heme synthesis in normal mouse liver and mouse liver tumors, Cancer Res. 50 (1990) 2337-2340.
38. Z. Hua, S.L. Gibson, T.H. Foster, R. Hilf, Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo, Cancer Res. 55 (1995) 1723-1731.
39. J. Bedwell, A.J. MacRobert, D. Phillips, S.G. Bown, Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumour model, Br. J. Cancer 65 (1992) 818-824.
40. C. Fritsch, J. Batz, K. Bolsen, K. Schulte, T. Ruzicka, G. Goerz, Exogenous 5-aminolevulinic acid induces the porphyrin biosynthesis in human skin organ cultures with different porphyrin patterns in normal and malignant human tissue, SPIE Proc. 2371 (1995) 215-220.
41. K. Wolff, H. Hönigsmann, W. Rauschmeier, G. Schuler, R. Pechlaner, Microscopic and fine structural aspects of porphyrias, Acta Dermatovener. (Stockholm) Suppl. 100 (1982) 17-28.
42. N. van der Veen, H.L.L.M. van Leengoed, W.M. Star, In vivo fluorescence kinetics and photodynamic therapy using 5-aminolevulinic acid-induced porphyrin: increased damage after multiple irradiations, Br. J. Cancer 70 (1994) 867-872.
43. W.M. Star, H.P. Marijnissen, A.E Van Den Berg-Blok, J.A.C. Versteeg, K.A.P Franken, H.S. Reinhold, Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers, Cancer Res. 46 (1986) 2532-2540.
44. J. Leveckis, N.J. Brown, M.W.R. Reed, The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo, Br. J. Cancer 72 (1995) 1113-1119.
45. M. Dellian, C. Abels, G.E.H. Kuhnle, A.E. Goetz, Effects of photodynamic therapy of leukocyte-endothelium interaction: differences between normal and tumour tissue, Br. J. Cancer 72 (1995) 1125-1130.
46. M. Dellian, C. Richert, F. Gamarra, A.E. Goetz, Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers, Int. J. Cancer 65 (1996) 1-3.
47. C. Abels, M. Dellian, R.-M. Szeimies, P. Steinbach, C. Richert, A.E. Goetz, Targeting of the tumor microcirculation with a new photosensitizer, Proc. SPIE 2625 (1996) 164-169.
48. D. Kessel, K. Woodburn, B.W. Henderson, C.K. Chang, Sites of photodamage in vivo and in vitro by a cationic porphyrin, Photochem. Photobiol. 62 (1995) 875-881.
49. J. Denekamp, Vascular endothelium as the vulnerable element in tumours, Acta Radiol. Oncol. 23 (1984) 217-225.